BioCentury | Jan 6, 2017
Financial News

Neon raises $70M in series B

...series B round led by new investor Partner Fund Management. New investors Fidelity, Wellington Management, Inbio Ventures...
BioCentury | Jan 6, 2017
Finance

Neon’s next steps

...which closed on Jan. 5. Additional new investors Fidelity Management and Research Co., Wellington Management, Inbio Ventures...
BioCentury | Jan 6, 2017
Financial News

Neon completes venture financing

...series B round led by new investor Partner Fund Management. New investors Fidelity, Wellington Management, Inbio Ventures...
BioCentury | Aug 18, 2016
Financial News

Avelas' series C round brings in $20M

...last about two years. The company also intends to explore development of new targeted therapeutics. Inbio Ventures'...
BioCentury | May 19, 2014
Company News

Proteon board of directors update

...Mass. Business: Cardiovascular Appointed: Tim Haines, partner at Abingworth; and Dmitry Kobyzev, investment manager at Inbio Ventures WIR...
BioCentury | May 17, 2014
Financial News

Proteon secures $45 million in D round

...option to acquire Proteon. Abingworth's Tim Haines joined Proteon's board along with Dmitry Kobyzev from Inbio Ventures...
Items per page:
1 - 6 of 6
BioCentury | Jan 6, 2017
Financial News

Neon raises $70M in series B

...series B round led by new investor Partner Fund Management. New investors Fidelity, Wellington Management, Inbio Ventures...
BioCentury | Jan 6, 2017
Finance

Neon’s next steps

...which closed on Jan. 5. Additional new investors Fidelity Management and Research Co., Wellington Management, Inbio Ventures...
BioCentury | Jan 6, 2017
Financial News

Neon completes venture financing

...series B round led by new investor Partner Fund Management. New investors Fidelity, Wellington Management, Inbio Ventures...
BioCentury | Aug 18, 2016
Financial News

Avelas' series C round brings in $20M

...last about two years. The company also intends to explore development of new targeted therapeutics. Inbio Ventures'...
BioCentury | May 19, 2014
Company News

Proteon board of directors update

...Mass. Business: Cardiovascular Appointed: Tim Haines, partner at Abingworth; and Dmitry Kobyzev, investment manager at Inbio Ventures WIR...
BioCentury | May 17, 2014
Financial News

Proteon secures $45 million in D round

...option to acquire Proteon. Abingworth's Tim Haines joined Proteon's board along with Dmitry Kobyzev from Inbio Ventures...
Items per page:
1 - 6 of 6